$2.00
0.073.63%
At close: -
$1.91
-0.09-4.48%
After Hours: Jun 6, 4:47 PM EDT
Comments
Loading...
Quipt Home Medical Analyst Ratings and Price Targets | NASDAQ:QIPT | Benzinga
Quipt Home Medical Corp has a consensus price target of $5.23 based on the ratings of 3 analysts. The high is $10 issued by Raymond James on February 16, 2024. The low is $1.7 issued by Canaccord Genuity on May 13, 2025. The 3 most-recent analyst ratings were released by Benchmark, Canaccord Genuity, and Benchmark on May 14, 2025, May 13, 2025, and August 21, 2024, respectively. With an average price target of $4.23 between Benchmark, Canaccord Genuity, and Benchmark, there's an implied 121.59% upside for Quipt Home Medical Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Canaccord Genuity
Raymond James
1calculated from analyst ratings
Analyst Ratings for Quipt Home Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2025 | Buy Now | 109.38% | Benchmark | Bill Sutherland67% | $6 → $4 | Maintains | Buy | Get Alert |
| 05/13/2025 | Buy Now | -11.01% | Canaccord Genuity | Richard Close45% | $4 → $1.7 | Downgrade | Buy → Hold | Get Alert |
| 08/21/2024 | Buy Now | 266.42% | Benchmark | Bill Sutherland67% | $9 → $7 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | 214.07% | Canaccord Genuity | Richard Close45% | $8 → $6 | Maintains | Buy | Get Alert |
| 05/20/2024 | Buy Now | 371.11% | Benchmark | Bill Sutherland67% | $10 → $9 | Maintains | Buy | Get Alert |
| 05/17/2024 | Buy Now | 318.76% | Canaccord Genuity | Richard Close45% | $9 → $8 | Maintains | Buy | Get Alert |
| 02/16/2024 | Buy Now | 423.45% | Raymond James | Rahul Sarugaser20% | $10 → $10 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/20/2023 | Buy Now | 423.45% | Benchmark | Bill Sutherland67% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/14/2023 | Buy Now | 475.8% | Canaccord Genuity | Richard Close45% | → $11 | Assumes | → Buy | Get Alert |
| 05/17/2023 | Buy Now | 423.45% | Benchmark | Bill Sutherland67% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/15/2023 | Buy Now | 423.45% | Benchmark | Bill Sutherland67% | → $10 | Reiterates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | 423.45% | Benchmark | Bill Sutherland67% | → $10 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Quipt Home Medical (QIPT) stock?
The latest price target for Quipt Home Medical (NASDAQ:QIPT) was reported by Benchmark on May 14, 2025. The analyst firm set a price target for $4.00 expecting QIPT to rise to within 12 months (a possible 109.38% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Quipt Home Medical (QIPT)?
The latest analyst rating for Quipt Home Medical (NASDAQ:QIPT) was provided by Benchmark, and Quipt Home Medical maintained their buy rating.
When was the last upgrade for Quipt Home Medical (QIPT)?
There is no last upgrade for Quipt Home Medical
When was the last downgrade for Quipt Home Medical (QIPT)?
The last downgrade for Quipt Home Medical Corp happened on May 13, 2025 when Canaccord Genuity changed their price target from $4 to $1.7 for Quipt Home Medical Corp.
When is the next analyst rating going to be posted or updated for Quipt Home Medical (QIPT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quipt Home Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quipt Home Medical was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
Is the Analyst Rating Quipt Home Medical (QIPT) correct?
While ratings are subjective and will change, the latest Quipt Home Medical (QIPT) rating was a maintained with a price target of $6.00 to $4.00. The current price Quipt Home Medical (QIPT) is trading at is $1.91, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
